Replies to post #413 on Trius Therapeutics, Inc. (TSRX)

[136]

Right, even if they don't get bought out they will steal the entire market share from pfizer which is currently worth ~1.4 Billion.

So trust me, even Pfizer doesn't want to let that happen. Even more likely IMO that Pfizer will outbid Cubist for the Tedizolid.